According to filings with the U.S. Securities and Exchange Commission, Egg Medical is raising up to $13,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Egg Medical
At Egg Medical we believe that all interventional physicians, nurses and techs deserve better protection from scatter radiation in the lab. Egg Medical’s EggNest Radiation Protection System reduces radiation exposure for everyone, in every case, by up to >99% without compromising workflow, because #ScatterMatters! Our Goal is to reduce the scatter radiation exposure of physicians, surgeons, nurses, technicians and others who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients.

To learn more, visit https://eggmedical.com/
LinkedIn: https://www.linkedin.com/company/egg-medical/

Contact:
Scott Youngstrom, Chief Financial Officer
https://www.linkedin.com/in/scott-youngstrom-7086396/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.